Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 68Ga-NOTA-BBN-RGD
Sponsor: Peking Union Medical College Hospital
Collaborators: National Institute for Biomedical Imaging and Bioengineering (NIBIB)